Data as of 4:00pm ET
| +0.02 / +0.66%|
The 3 analysts offering 12-month price forecasts for Ventrus Biosciences Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +194.12% increase from the last price of 3.06.
The current consensus among 3 polled investment analysts is to Buy stock in Ventrus Biosciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.